These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 21393583)

  • 1. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
    Bu DX; Tarrio M; Maganto-Garcia E; Stavrakis G; Tajima G; Lederer J; Jarolim P; Freeman GJ; Sharpe AH; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1100-7. PubMed ID: 21393583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.
    Gotsman I; Grabie N; Dacosta R; Sukhova G; Sharpe A; Lichtman AH
    J Clin Invest; 2007 Oct; 117(10):2974-82. PubMed ID: 17853943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.
    Lucas CL; Workman CJ; Beyaz S; LoCascio S; Zhao G; Vignali DA; Sykes M
    Blood; 2011 May; 117(20):5532-40. PubMed ID: 21422469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.
    Haspot F; Fehr T; Gibbons C; Zhao G; Hogan T; Honjo T; Freeman GJ; Sykes M
    Blood; 2008 Sep; 112(5):2149-55. PubMed ID: 18577709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke.
    Ren X; Akiyoshi K; Vandenbark AA; Hurn PD; Offner H
    Stroke; 2011 Sep; 42(9):2578-83. PubMed ID: 21737801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
    Keir ME; Freeman GJ; Sharpe AH
    J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo.
    Habicht A; Kewalaramani R; Vu MD; Demirci G; Blazar BR; Sayegh MH; Li XC
    Am J Transplant; 2007 Dec; 7(12):2683-92. PubMed ID: 17924994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
    Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
    J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
    Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
    J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
    D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
    J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
    Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
    J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
    Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
    Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
    Foks AC; Engelbertsen D; Kuperwaser F; Alberts-Grill N; Gonen A; Witztum JL; Lederer J; Jarolim P; DeKruyff RH; Freeman GJ; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):456-65. PubMed ID: 26821944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum.
    Lázár-Molnár E; Gácser A; Freeman GJ; Almo SC; Nathenson SG; Nosanchuk JD
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2658-63. PubMed ID: 18268348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.